Professional Documents
Culture Documents
SOAP NOTE 2
Subjective Information
Age: 56 y/o
DOB: 8/3/1963
Gender: Male
Advanced directives: No
Insurance: Aetna
Ethnicity: Caucasian
Chief Complaint:
P.R. is a 56-year-old male that presents for a follow up visit and lab review. He had lab work
completed on 1/28/20 in order to review at this visit. He was last evaluated at this office in 2017,
but then resumed care through the Veterans Affairs (VA). He wants to reestablish primary care
with Tennova. He explained that he stopped taking his Atorvastatin about 1 month ago in order
to reassess his cholesterol levels and possibly stop the medication completely. He reports he is
currently stressed with work and purchasing a new house, so he has not been eating healthy. He
denies any changes in his health except in May 2019 he had a work-related injury. He was struck
SOAP NOTE 2 2
with an osteotome in the right side of his face which required surgical repair. Denies any deficits.
cardiac events.
Dermatologic: Denies history of psoriasis, atopic dermatitis, rosacea, skin cancer, and urticaria.
Genitourinary: History of BPH. Denies history of kidney stones, bladder infections, or kidney
disease.
mood disorders.
Health Maintenance:
Diagnostic tests:
- Last colonoscopy in 2019. Recall 3 years.
SOAP NOTE 2 3
Specialists: None
Immunizations: Up to date
- Influenza: 10/19
Social History:
Personal History:
Marital status: Married
Health Habits:
Family History:
Medications:
Adverse Effects: Diarrhea, arthralgia, nasopharyngitis, nausea, dyspepsia, urinary tract infection
Cyclobenzaprine 10mg tablet. Take 1 tablet by mouth TID as needed for muscle spasms.
(Lexicomp, 2020c)
Contraindications: History of asthma or urticaria with aspirin or NSAID use, bypass graft
(Lexicomp, 2020f)
Allergies:
General:
Diet:
Denies any bruising, redness, abrasions, lesions, or discoloration to skin. Denies changes in nails
Eyes:
Denies vision disturbances, dry eye, watery eyes, discharge, and trauma. Wears glasses.
Ears:
Nose:
Cardiovascular:
syncope.
Gastrointestinal:
Reports intermittent “heart burn” after meals. Denies abdominal pain, nausea, vomiting, or
diarrhea.
Genitourinary:
Musculoskeletal:
SOAP NOTE 2 7
Reports intermittent low back pain without radiation to legs. Denies change in range of motion,
Neurologic:
Objective Information:
Physical Exam:
Vital Signs:
Temperature: 98F
Heart Rate: 75
Respirations: 16
BP: 121/80
Height: 5’7”
Weight: 205lbs
Focused exam:
General Appearance
Patient is a 56-year-old male who is well groomed, wearing appropriate dress for season, and
cooperative. He is alert. No distress noted. Sitting in chair when I enter the room.
Oriented to person, place, and time. Speech is clear and understandable. Sensory and motor
Skin/hair/nails
SOAP NOTE 2 8
Skin is fair, warm, dry. Hair is brown and clean. Scar to right cheek (2cm). No bruising,
abrasions, redness, lesions, or swelling noted. Nails are trimmed with no cracking or
discoloration. Nail beds are pink, capillary refill is < 3 seconds, and no evidence of clubbing of
Head
Neck
No jugular vein distention noted. No bruits noted on auscultation of the carotid arteries. Trachea
is midline and freely mobile. Neck is supple with full range of motion. No nodules or masses
Eyes
Pupils are equal, round, and reactive to light. Conjunctiva is pink and sclera is white. Extraocular
Ears
Symmetrical. Bilateral ear canals are patent. Tympanic membranes are pearly, gray with cone of
Nose
Mucosa is pink without discharge. Nasal septum appears midline. No tenderness noted upon
palpation of frontal and maxillary sinuses. Nares are patent, no erythema, or drainage noted.
Lips are moist. Dentition is intact with no obvious caries. Buccal membranes are pink and moist.
Tongue is pink, midline, and moist. No erythema or exudate present on posterior pharynx.
respirations per minute. No visible use of accessory muscles. No crepitus, masses, lesions, noted
to anterior or posterior chest. Clear auscultated lung sounds throughout anterior and posterior
Heart/Peripheral Vascular
No signs of acute distress. PMI is palpable at the left midclavicular line at the 5th intercostal
space. No heaves, lifts, thrills or thrusts at PMI. S1 and S2 are audible with regular rhythm. No
splitting, gallops, rubs, murmurs or snaps at the five cardiac points of auscultation. Dorsalis pedis
Gastrointestinal
Abdomen is rounded, symmetrical. Skin color is fair. Active bowel sounds in all four quadrants.
No aortic bruits. Tympany percussed in all four quadrants. Liver not palpable. Abdomen is soft
to light and deep palpation. No masses, tenderness, or presence of organomegaly with palpation.
Genitourinary
Examination deferred.
Musculoskeletal
Patient is able to walk around room and change positions independently. Joints are appropriate
size, symmetrical, and contour. No ecchymosis, erythema, or changes in the skin integrity. No
No edema, masses, atrophy, hypertrophy, increased tone irregularities noted in any muscle
groups bilaterally. No scoliosis or deformities palpated of spine. No pain with palpation of spine.
SOAP NOTE 2 10
Labs on 1/28/20
CBC – WDL
Lipid Panel – Total Cholesterol: 211, LDL: 141, HDL: 50, Triglycerides: 95
Labs on 10/12/17
CBC – WDL
Lipid Panel – Total Cholesterol: 164, LDL: 105, HDL: 36, Triglycerides: 35
Assessment Information:
Diagnostic Criteria
Patients with hyperlipidemia are often asymptomatic and diagnosed on routine screening
examinations (Santos, 2019). Diagnostic criteria for hyperlipidemia is based on the following lab
LDL:
* Optimal: <70mg/dL
* High: 160-189mg/dL
Total Cholesterol:
* Optimal: <170mg/dL
* Desirable: <200mg/d
* High: >240mg/dL
HDL:
* Low: <40mg/dL
Triglycerides:
* Ideal: <100mg/dL
* Desirable: 100-<150mg/dL
This patient was previously diagnosed with hyperlipidemia. Recommendations for drug
therapy is based on age, comorbidities, and cardiovascular risk (Santos, 2019). The patient’s total
cholesterol and LDL have increased and his triglyceride level has decreased since his last visit in
2017. He explained that he stopped taking Atorvastatin about 4 weeks ago in order to get an
accurate reading on his current cholesterol level. The patient’s atherosclerotic cardiovascular
disease (ASCVD) risk score was calculated in the office and resulted as 6.1%. We discussed
these results with the patient. According to the recommendations he does not have to be on a
statin medication at this time because his risk is <7.5%. He is requesting to trial modifying his
Diabetes mellitus type 2 affects nearly 8 percent of the United States population
(McCullouch & Hayward, 2019). Risk factors include age greater than 45 years, obesity, family
history of vascular disease (McCullouch & Hayward, 2019). Screening tests for type 2 diabetes
include a fasting plasma glucose, hemoglobin A1C, and an oral glucose tolerance test
(McCullouch & Hayward, 2019). According to McCullouch & Hayward (2019), diagnosis of
diabetes mellitus is based on the following test findings and must be confirmed on a subsequent
* Two-hour plasma glucose > 200mg/dL during oral glucose tolerance test
discussed what diabetes is and the potential long-term effects of the disease. He is motivated to
diagnosed clinically. A trial of proton-pump inhibitors can provide both diagnosis and initial
treatment of this condition (Zuckerman & Carrion, 2019). “Heartburn" and regurgitation are the
most common symptoms, which usually occur after meals (Zuckerman & Carrion, 2019).
Symptoms are typically worse if the patient is lying down or bending over (Zuckerman &
Carrion, 2019). Treatment goals aim to control symptoms and prevent complications
(Zuckerman & Carrion, 2019). This patient has an established diagnosis of GERD and has been
on proton-pump inhibitors, which are the mainstay therapy for this condition (Zuckerman &
SOAP NOTE 2 13
Carrion, 2019). He is current taking over the counter omeprazole and is experiencing
breakthrough symptoms.
of patients in primary care. Symptoms of depression include low mood, loss of interest, reduced
energy, appetite changes, sleeping change, and poor concentration (MacKinnon, 2019). The
Depression Scale of the Patient Health Questionnaire (PHQ-9) is a quick, helpful tool to perform
depression screening in the primary care setting (MacKinnon, 2019). The main antidepressant
more which are best selected based on individual factors (MacKinnon, 2019). This patient has an
established diagnosis of depression and has been taking combination therapy of escitalopram and
Approximately 84% of adults will experience low back pain at some point in their lives
(Knight et al., 2020). The majority of patients in primary care have nonspecific back pain that is
self-limiting. This patient has an established diagnosis and has had intermittent low back pain for
several years. He explained that he will occasionally “tweak” his back and will require a couple
of days of pharmacologic therapy to improve. Nonpharmacologic treatment for low back pain
includes heat, massage, exercises, acupuncture, and more (Knight et al., 2020). Recommended
with muscle relaxants if necessary (Knight et al., 2020). This patient was previously prescribed
meloxicam and cyclobenazaprine for low back pain and reports taking them about once a month
as needed.
SOAP NOTE 2 14
Benign Prostatic Hyperplasia (BPH) can lead to increased urinary frequency, hesitancy,
urgency, weak urinary stream, or nocturia (Cunningham & Kadmon, 2020). This is a common
condition that increases in prevalence as men age (Cunningham & Kadmon, 2020). Initial
(Cunningham & Kadmon, 2020). This patient has an established diagnosis of BPH and has been
taking tamsulosin with improvement in his symptoms of weak urinary stream and hesitancy.
DIAGNOSES:
ICD 10 codes:
E78.5 – Hyperlipidemia
R73.03 – Prediabetes
CPT codes:
99204 – Office Visit, New Patient, 2 Key Components: Detailed History; Detailed Examination;
PLAN:
- Labs reviewed with patient. Discussed increased cholesterol levels and increased
- Pt was previously on Atorvastatin 20mg daily but stopped taking it about 4 weeks ago in
anticipation of his lab draw. Patient notified that his ASCVD risk score is 6.1%.
Discussed ASCVD risk score criteria for statin therapy. Discussed lifestyle changes
including diet modifications and exercise. Pt appears to be very motivated and wants to
trial lifestyle modifications at this time. Discussed limiting fried and fatty foods and
increasing vegetable and protein intake. Will reassess a fasting lipid panel in 3 months to
- Patient currently taking Omeprazole 20mg tablet daily over the counter. Pt reports he is
occasionally having breakthrough symptoms of GERD. He has tried Protonix in the past
release tablet by mouth once a day. Dispense: 30 capsules. Refill:2. Pt notified of online
copay card. If this medication is too expensive, discussed taking two tablets of
Omeprazole 20mg daily. Discuss avoiding large meals and avoiding laying down after
- Discussed continuing Buspar and Escitalopram for depression as he is doing well. Will
refill.
o Buspar 15mg tablets. Take 1 tablet by mouth twice a day. Dispense: 60 tablets.
Refill: 5
Refill: 5
months.
SOAP NOTE 2 16
- Discussed continuing taking Meloxicam and Cyclobenazaprine as needed for low back
pain. Recommended home stretches or yoga for low back pain. Discussed not using
Meloxicam daily due to risk of ulcers and impact on kidney function. Take Meloxicam
with food. Pt notified that he should not drive while taking Cyclobenazaprine. He states
that he infrequently takes this medication, only about once or twice a month, and does not
need a refill at this time. He can call the office if he needs a refill before next visit.
Refill: 5
urine.
- Lifestyle modifications including diet and exercise discussed with patient. The
classified as prediabetic. We discussed eliminating his soda intake and replacing it with
water.
- Release of information sign to obtain records from the VA and Parkridge hospital.
- Routine eye exam scheduled for this summer. Next colonoscopy will be in 2021.
cholesterol level with fasting labs. Wellness examination will be in 6 months. Advance
directives not discussed at this visit but will be reviewed at his next wellness
References
com.proxy.lib.utc.edu/contents/medical-treatment-of-benign-prostatic-
hyperplasia?search=bph&source=search_result&selectedTitle=1~150&usage_type=defau
lt&display_rank=1#H619703294
Knight, C., Deyo, R., Staiger, T., & Wipf, J. (2020). Treatment of acute low back pain.
com.proxy.lib.utc.edu/contents/treatment-of-acute-low-back-
pain?search=low%20back%20pain%20treatment&source=search_result&selectedTitle=1
~150&usage_type=default&display_rank=1
https://www-uptodate-com.proxy.lib.utc.edu/contents/atorvastatin-drug-
information?search=atorvastatin&source=search_result&selectedTitle=1~134&usage_typ
e=panel&kp_tab=drug_general&display_rank=1
https://www-uptodate-com.proxy.lib.utc.edu/contents/buspirone-drug-
information?search=buspirone&source=search_result&selectedTitle=1~104&usage_type
=panel&kp_tab=drug_general&display_rank=1
https://www-uptodate-com.proxy.lib.utc.edu/contents/cyclobenzaprine-drug-
information?search=cyclobenzaprine&source=search_result&selectedTitle=1~40&usage
_type=panel&kp_tab=drug_general&display_rank=1
SOAP NOTE 2 18
https://www-uptodate-com.proxy.lib.utc.edu/contents/escitalopram-drug-
information?search=escitalopram&source=search_result&selectedTitle=1~122&usage_ty
pe=panel&kp_tab=drug_general&display_rank=1
https://www-uptodate-com.proxy.lib.utc.edu/contents/meloxicam-drug-
information?search=meloxicam&source=search_result&selectedTitle=1~18&usage_type
=panel&kp_tab=drug_general&display_rank=1
https://www-uptodate-com.proxy.lib.utc.edu/contents/tamsulosin-drug-
information?search=tamsulosin&source=search_result&selectedTitle=1~34&usage_type
=panel&kp_tab=drug_general&display_rank=1
https://online.epocrates.com/diseases/5521/Depression-in-adults/Definition
McCulloch, D. & Hayward, R. (2019). Screening for type 2 diabetes mellitus. UpToDate.
2-diabetes-
mellitus?search=diabetes%20mellitus%20type%202§ionRank=1&usage_type=defau
lt&anchor=H6&source=machineLearning&selectedTitle=3~150&display_rank=3#H6
from https://online.epocrates.com/diseases/17011/Hypercholesterolemia/Key-Highlights
Zuckerman, M.J. and Carrion, A.F. (2019). Gastroesophageal reflux disease. Epocrates.
SOAP NOTE 2 19
disease/Treatment-Approach